ABSTRACT. Forty-three twin lamb fetuses of 121 f: 1 d gestation were catheterized and received i.v. saline (n = 8), 0.75 mg/kg/h cortisol for 60 h (n = IS), 5 ~g / k g thyrotropin-releasing hormone (TRH) every 12 h for five doses (n = 9), or cortisol and TRH (n = 11) before delivery at 128 + 1 d. After delivery, the lambs were randomized for natural sheep surfactant treatment or sham treatment, ventilated for 75 min, and killed. Superoxide dismutase, catalase, and glutathione peroxidase activities were measured in fetal lung tissue. Superoxide dismutase and catalase activities were increased in both the corticosteroid (p < 0.001) and the corticosteroid with TRH ( p < 0.01) groups.
After delivery, the lambs were randomized for natural sheep surfactant treatment or sham treatment, ventilated for 75 min, and killed. Superoxide dismutase, catalase, and glutathione peroxidase activities were measured in fetal lung tissue. Superoxide dismutase and catalase activities were increased in both the corticosteroid (p < 0.001) and the corticosteroid with TRH ( p < 0.01) groups.
Glutathione peroxidase activity was higher after prenatal corticosteroid treatment, but statistical significance was not reached ( p = 0.06). Although prenatal exposure to corticosteroids increased superoxide dismutase, catalase, and glutathione peroxidase activities, TRH alone or TRH added to corticosteroids provided no additional benefit. Lambs treated with surfactant had higher lung catalase activities than lambs that did not receive surfactant, probably secondary to the presence of catalase activity in the surfactant preparation. Increased pulmonary antioxidant enzyme activity may be an additional feature of the overall beneficial effect of corticosteroids on fetal lung development. (Pediatr Res 30: 518-521, 1991) Abbreviations GPX, glutathione peroxidase SOD, superoxide dismutase T3, triiodothyronine T4, thyroxine ~~~, -t h~r o t r o~i n -r e l e a s i n~ hormone VEI, ventilatory efficiency index Exposure of the lung to high concentrations of oxygen produces endothelial and alveolar type I cell damage associated with alveolar-capillary leakage, lung edema, and, ultimately, deterioration of lung function. Alveolar type I1 cells synthesize and secrete surfactant and maintain the integrity of the alveolar epithelium by proliferation and differentiation into type I cells and are relatively resistant against oxygen toxicity secondary to a high antioxidant enzyme activity (1). The foremost intracellular antioxidant enzymes are SOD, catalase, and GPX. SOD catalyzes the dismutation of the superoxide radical, whereas catalase and GPX both sequester hydrogen peroxide formed from the dismutation reaction. At higher concentrations of hydrogen peroxide, catalase has a greater scavenging activity than GPX. Antioxidant enzyme activities increase rapidly, in parallel with phospholipid content, during the final 10 to 15% of gestation in the hamster (2), rat (2-5), rabbit (2, 6), guinea pig (2), lamb (7, 8) , and human fetus (9) . Under normoxic conditions, free oxygen radicals are kept in check by the antioxidant enzymes, but during hyperoxia production of free oxygen radicals increases rapidly and may overwhelm the capacity for detoxification. The premature infant with surfactant deficiency may be further compromised by an underdeveloped antioxidant defense system when exposed to high concentrations of oxygen. Accelerated maturation of the antioxidant enzyme system in the fetal lung may therefore be of clinical benefit.
Various hormones influence pulmonary differentiation. Corticosteroids (cortisol, dexamethasone) and thyroid hormones (Tj and T4) accelerate surfactant synthesis and have additive or synergistic effects on morphologic and biochemical development of nonventilated fetal lung (10). Ikegami et al.
(1 1) treated pregnant rabbits with betamethasone, T3, TRH alone, or combinations of betamethasone plus T j or TRH. Combined TRH and corticosteroid treatment significantly augmented the response of the ventilated preterm rabbit lung to surfactant replacement therapy, suggesting that TRH is an attractive agent for potential clinical use in augmenting pulmonary development, especially because it readily crosses the placenta, causing both thyroid axis stimulation and increased circulating prolactin (12, 13) . Whereas corticosteroids stimulate (14) , Tj depresses antioxidant enzyme synthesis in fetal rat lung (15) . Preliminary data suggest that TRH depresses antioxidant enzyme maturation in fetal rat lung (16) . Because of the potential clinical usefulness of corticosteroids and TRH in ameliorating neonatal respiratory distress syndrome, we tested their effect on antioxidant enzyme activity in ventilated immature lamb lungs.
MATERIALS AND METHODS
Fetal catheterization and hormone treatments. Animals used in this study were the sheep used for lung function studies reported by Ikegami et al. (17) . In brief, date-mated mixed Western breed sheep with twin pregnancies underwent hysterotomy at 121 + 1 d gestation (term is 150 d). After exposure of a fetal hindlimb, arterial and venous catheters were introduced to the level of the abdominal aorta and inferior vena cava.
respectively. Starting at 125 + 1 d gestation, the ewes were randomized into four treatment groups: saline, corticosteroid, TRH, or the combination of corticosteroid and TRH. Each twin fetus received the same infusion. Eight fetuses received a continuous infusion of heparinized saline (1 U/mL) at 2 mL/h and 5 intermittent bolus injections of normal saline (1 mL/kg estimated body weight) at 12-h intervals. Fifteen fetuses received a continuous infusion of 0.75 mg cortisol/kg estimated body weight/h (Solu-Cortef; Upjohn, Kalamazoo, MI) diluted in 2 mL of heparinized normal saline and five intermittent bolus injections of normal saline (1 mL/kg estimated body weight). Nine fetuses received a continuous infusion of heparinized normal saline at 2 mL/h and five intermittent bolus injections of 5 pg/ kg estimated fetal weight of synthetic TRH (Bachem, Torrance, CA) at 12-h intervals. Eleven fetuses received both continuous cortisol infusion (0.75 mg/kg/h) and intermittent bolus injections of TRH (5 pg/kg every 12 h). All infusions were given i.v. until delivery.
Postnatal studies. At 128 k 1 d gestation, after 60 h of cortisol or saline infusion and 7 h after the 5th TRH or saline injection, fetuses were delivered by cesarean section. An endotracheal tube was inserted, and one of each pair of twin lambs was randomly assigned to treatment with 50 mg/kg natural sheep surfactant and the other received sham treatment. Initial ventilator settings were: rate, 40 breathslmin; inspiratory time, 0.7 s; positive endexpiratory pressure, 3 cm H20; and 100% oxygen. An umbilical artery catheter was placed in the thoracic aorta, and ventilation was stabilized by adjustments in peak inspiratory pressures. Subsequently, only the peak inspiratory pressure was altered to maintain Pco2 values between 4.0 and 5.3 kPa. Core body temperature was maintained with radiant heaters and heating lamps. At 15 min of age, each animal was given 5 pCi I3lI-albumin via the umbilical artery catheter (17) . Dynamic compliance and VEI values were obtained during ventilation (1 8). The VEI formula equals 3800:APf.Pco2, where 3800 is a constant relating to C 0 2 production (mL. kPa. kg-'. min), AP is the difference between peak inspiratory and positive end-expiratory pressure, f is the ventilatory frequency, and Pcoz is the arterial C 0 2 pressure in kPa. After 75 rnin of ventilation, blood was collected for Hb measurements and the lambs were killed. The lungs were removed and weighed. A pressure-volume curve was made, and the lungs were lavaged six times with cold saline. The lung tissue was homogenized in 500 mL normal saline and centrifuged at 15 000 x g for 10 min at 4°C. The supernatant was used for antioxidant enzyme assays and DNA content. Hb concentrations were determined in lung homogenates and blood and used to correct the amount of '311-albumin (19) and antioxidant enzyme activities (20) contributed by intravascular blood.
Antioxidant enzyme activities and DNA. Total SOD activity was assayed by inhibition of the reduction of cytochrome c in the xanthine oxidase reaction (2 1) using a modification described by Forman and Fisher (1). Endogenous reductants in the samples, which could interfere with the assay by producing nonsuperoxide-dependent cytochrome c reduction, were eliminated by mixing the sample and 5 x M cytochrome c in 0.6 mL of 0.5 M potassium phosphate buffer, pH 7.8, and allowing the reduction and reoxidation by endogenous cytochrome oxidase of the cytochrome c to occur. The reaction was followed at 550 nm in a DU-7 spectrophotometer (Beckman Instruments, Inc., Fullerton, CA). After incubation in the small volume, low5 M cyanide was added to inhibit cytochrome oxidase, followed by xanthine, xanthine oxidase, and H 2 0 to a final volume of 3 mL. One unit of SOD equaled 50% inhibition of cytochrome c reduction.
Catalase activity was measured by the rate of reduction of hydrogen peroxide substrate, followed spectrophotometrically at 240 nm (22) . One unit of catalase equals 1 pmol hydrogen peroxide decomposed/min at 25°C.
GPX activity was assayed spectrophotometrically at 340 nm by the rate of oxidation of NADPH (23) . The assay mixture for measurement of this cytosolic enzyme includes cumene hydroperoxide as primary substrate, with sodium azide added to inhibit contributing activity from catalase enzyme.
The DNA content of the tissue samples was determined by the fluorimetric method of Erwin et al. (24 values in the saline controls and the TRH, corticosteroid, and corticosteroid and TRH groups subdivided by surfactant treatment status. Although pulmonary antioxidant enzyme activities tended to be higher in subgroups treated with surfactant than in subgroups that did not receive surfactant, these differences were significant only for catalase activity in the corticosteroid group ( p < 0.005). Corticosteroid treatment significantly increased lung SOD and catalase activity, irrespective of surfactant treatment, but TRH treatment did not affect activity of either enzyme. GPX values varied considerably within each group and tended to increase after prenatal treatment with corticosteroids, but not with TRH. Comparison of the antioxidant enzyme activities between the two groups that received corticosteroids and the two groups that did not receive corticosteroids confirmed these findings. In the corticosteroid group, SOD activity was 68 (Fig. 2) , whereas the accumulation of intravascular "'I-albumin in the total lung (lung tissue plus alveolar wash) and in the alveolar lavage alone decreased significantly (r = 0.66 and 0.68, respectively; p < 0.001 for both) (Fig. 3) . These effects also correlated with surfactant treatment (Figs. 2 and 3) .
Catalase activity in the surfactant preparation was 20.26 f 0.49 U/mg surfactant lipid ( n = 6); SOD and GPX activities were not detected. This suggests that the increase in lung tissue catalase activity in surfactant-treated lambs compared with con- trols is secondary to an average uptake of 29.9% of the catalase present in the surfactant preparation.
DISCUSSION
The focus of these experiments was to evaluate lung antioxidant enzyme activity in preterm lambs after fetal hormone and surfactant treatments given at doses and for durations comparable to those that have been used clinically.
Corticosteroids alone considerably improved lung function measurements: compliance increased, gas exchange as indicated by the ventilation index improved, maximal lung volumes and volumes at low transpulmonary pressures increased as measured from pressure-volume curves, and the movement of labeled albumin into and out of the lungs as a measurement of the tendency to develop pulmonary edema decreased ( I 7). Surfactant pool sizes were not affected by corticosteroids. Results with TRH alone were not different from the controls, and no significant additive effects of combined corticosteroid and TRH therapy on postnatal lung function or alveolar saturated phosphatidylcholine pools were seen ( 1 7).
Baseline values of pulmonary antioxidant enzyme activities in the preterm lambs in the present study were comparable to values obtained previously in fetal sheep of similar gestational age (8) and indicate that 75 min of mechanical ventilation with 100% oxygen after birth by cesarean section did not influence antioxidant enzyme activity. Similarly, although surfactant administration at birth was associated with higher arterial Por levels, antioxidant enzyme activity was not affected, at least for periods up to 75 min. Prenatal corticosteroid administration increased the activities of SOD, catalase, and GPX in fetal lamb lung, but the latter failed to reach statistical significance. TRH STEROIDS, TRH, AND ANTI0 alone or in addition to corticosteroids did not provide additional benefits in pulmonary antioxidant enzyme activity, nor did it decrease levels of activity. Lung catalase activity was higher in lambs treated with natural sheep surfactant at birth. Natural lung surfactants contain measurable amounts of SOD and catalase activities and can increase antioxidant enzyme content in alveolar epithelial cells (25) . The surfactant preparation used in this study contained catalase activity, whereas SOD and GPX activities were below detectable levels. Liposome encapsulation of catalase permits uptake by alveolar type I1 cells in vitro and renders them more resistant to oxidant stress with hydrogen peroxide (26) . The presence of catalase in the surfactant preparation may therefore explain the higher catalase activity in surfactant-treated lungs, especially because the percentage of exogenous catalase associated with lung tissue was similar to the percentage of exogenous surfactant phospholipids associated with lung tissue.
A combination of corticosteroids and thyroid hormones improves lung function in fetal rabbits (1 1) and in fetal sheep (10, 27) . Dexamethasone given to pregnant rats during late gestation accelerates the increase of the activities of pulmonary SOD, catalase, and GPX (14) , whereas adrenocortical blockade in fetal rats with metyrapone, an 1 I-@-steroid hydroxylase inhibitor, reduces both surfactant content and pulmonary antioxidant enzyme activities (28) . In rat fetal lung cell cultures, dexamethasone increases SOD and GPX activities, but not catalase activity (29, 30) . Whether this change in antioxidant enzyme activity is a direct effect of corticosteroids on alveolar type I1 cells or, as is the case for surfactant lipids, is largely mediated through induction of fibroblast-pneumonocyte factor (3 1) is unclear. Pulmonary SOD activity is lower in hypothyroid fetal lambs and returns to normal after Tq administration (7). However, injection of pregnant rats with T3 depresses pulmonary SOD, catalase, and GPX activities in the fetus (15) . Fetal offspring from methimazole-and propylthiouracil-treated hypothyroid pregnant rats have increased pulmonary antioxidant enzyme activities (32) . The present study confirms that pulmonary SOD, catalase, and GPX activities increase secondary to prenatal corticosteroid administration, but are not affected by prenatal TRH treatment. Estimation of antioxidant enzyme synthesis may provide additional information concerning enzyme responsitivity.
The correlation between catalase activity and protein leakage, an indicator of lung injury, was an unexpected finding, especially within the context of a much weaker correlation between catalase activity and compliance and VEI. The observation by Ikegami et al. (17) that prenatal corticosteroids improve lung function measures without changing surfactant pool sizes and our finding that corticosteroids induce an increase in catalase activity raise the issue of cause and effect. The induction of lung catalase activity by corticosteroids and the catalase activity of natural surfactant both have the potential to reduce pulmonary oxygen toxicity. Whether increased catalase activity affects lung function measures after only 75 min of mechanical ventilation, when lung injury is probably minimal, remains an issue that needs further study.
